Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial

Clinical trial NCT06662253 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06662253
Sponsor: Alexandre Tran
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism (VTE)Trauma Related Injuries

Start date: 2025-01-01
Primary completion: 2026-06-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.